Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Herbert E. Cohn is active.

Publication


Featured researches published by Herbert E. Cohn.


The Annals of Thoracic Surgery | 1986

Bronchoalveolar cell carcinoma of the lung.

Richard J. Greco; Robert M. Steiner; Scott Goldman; Howard Cotler; Arthur S. Patchefsky; Herbert E. Cohn

A multivariable analysis was performed of all patients registered and confirmed to have bronchoalveolar cell carcinoma of the lung in the Tumor Registry of Thomas Jefferson University Hospital between 1969 and 1983. These 122 patients were reviewed for age, sex, smoking history, occupational exposure, symptoms, radiographic findings, methods of diagnosis, clinical and pathologic staging, methods of treatment, survival, and complications of treatment. No correlation could be found in this series between a patients age, sex, smoking history, or occupational exposure and the incidence or outcome of the disease. Seventy-one of the 122 patients in this series were asymptomatic, and the carcinoma was discovered in them by routine chest roentgenogram. Of these asymptomatic patients, 50 were seen with pathologic stage I disease. Of the 51 symptomatic patients, 32 (65%) were seen with stage IIIm0 or IIIm1 disease. Despite medical evaluations, 77% of the T1 and T2 lesions required thoracotomy for diagnosis. The overall five-year survival rate was 42.3%, ranging from 75% for those with stage I disease to 8.7% for those with stage IIIm1 disease.


International Journal of Cancer | 2001

Treatment of metastatic melanoma with autologous, hapten‐modified melanoma vaccine: Regression of pulmonary metastases

David Berd; Takami Sato; Herbert E. Cohn; Henry C. Maguire; Michael J. Mastrangelo

A human cancer vaccine composed of autologous tumor cells modified with the hapten dinitrofluorobenzene (DNP) induces cell‐mediated immunity to the tumor cells and the development of inflammatory responses within metastatic sites. In this study we determined whether DNP vaccine could induce regression of established metastases. Ninety‐seven patients (83 evaluable) with surgically incurable metastatic melanoma were treated with DNP vaccine preceded by low‐dose cyclophosphamide. Tumor regression was assessed by standard criteria. The development of cell‐mediated immunity to melanoma‐associated antigens was measured by delayed‐type hypersensitivity (DTH) testing before and after DNP vaccine treatment. Survival analysis was performed by the Kaplan‐Meier method. There were 11 antitumor responses: 2 complete, 4 partial and 5 mixed. Both complete responses and 2 of the 4 partial responses occurred in patients with lung metastases. Response durations were as follows: partial responses—5, 6, 8 and 47+ months; and complete responses—12 and 29 months. Tumor regression required at least 4 months to become evident and in 2 cases maximum regression was not observed until 1 year after beginning treatment. Patients who exhibited tumor regression survived longer than those who did not (median survival times: responders, 21.4 months; non‐responders, 8.7 months; p = 0.010). DTH to DNP‐modified and unmodified autologous melanoma cells was induced in 87% and 42% of patients, respectively. The DTH response to unmodified cells was significantly associated with prolonged survival. Autologous DNP‐modified melanoma vaccine can induce clinically meaningful regression of metastases and small lung metastases appear to be unusually sensitive. The development of DTH to unmodified, autologous tumor cells may be an important indicator of the vaccines efficacy.


The Annals of Thoracic Surgery | 1989

Management of esophageal injuries.

Herbert E. Cohn; Alan Hubbard; Gerald Patton

A multiinstitutional study of 39 esophageal injuries treated between 1982 and 1988 and a comprehensive review of the literature revealed an unacceptably high mortality rate of more than 20%. Results of the current study indicated that prompt diagnosis and aggressive surgical management of esophageal injuries could improve the outcome and lower the associated mortality. The clinical experience and literature review allowed us to elaborate caveats and principles that, if adhered to, should improve the outcome in esophageal injuries.


Journal of The American College of Surgeons | 2003

Minimally invasive parathyroidectomy: 101 consecutive cases from a single surgeon

Ellen D. Dillavou; Herbert E. Cohn

BACKGROUND Intraoperative rapid parathyroid hormone (iPTH) assay is changing parathyroid surgery. One surgeons experience at a tertiary care hospital was followed as minimally invasive parathyroidectomy (MIP) was adopted. STUDY DESIGN In this prospective case study, patients underwent technitium 99m sestamibi scanning, iPTH monitoring, and MIP. A sestamibi-directed incision was made, and iPTH was measured preincision, preexcision of abnormal gland(s), and at 5- and 10-minute intervals. MIP was complete after gland(s) was excised and iPTH fell to less than 50% of preoperative levels. Routine discharge was on the day of surgery with daily calcium and calcitriol to minimize outpatient hypocalcemia. Secondary and tertiary hyperparathyroidism patients were excluded. RESULTS From December 1999 to June 2002, 101 patients underwent MIP. Patients were 27% men and 73% women, with two reoperations. Preoperation laboratory results averaged serum calcium 11.08 (normal 8.5 to 10.5 mg/dL) and parathyroid hormone (PTH) 169 pg/mL (normal 10 to 55 pg/mL). Average iPTH values at operative intervals were 152, 151, 68, and 50 pg/mL, respectively. Operation demonstrated 12% of patients had four-gland hyperplasia, 3% had double adenomas, 2% had parathyroid carcinomas, and 83% had single adenomas. Discharge on the day of surgery occurred in 83% of single-adenoma patients. Postoperative laboratory results averaged calcium 9.4 mg/dL (p < 0.001 versus preoperation) and PTH 48 pg/mL (p < 0.001). Fifteen patients (16%) had elevated PTH after operation, but without elevated calcium levels. One patient had persistant hyperparathyroidism. CONCLUSIONS MIP with iPTH monitoring is a safe and effective means of treating hyperparathyroidism. This approach allows for limited dissection and early discharge for the majority of patients.


Journal of The American College of Surgeons | 2000

The utility of sestamibi scanning in the operative management of patients with primary hyperparathyroidism

Ellen D. Dillavou; Jay S Jenoff; Charles M Intenzo; Herbert E. Cohn

BACKGROUND The role of imaging studies before parathyroidectomy has been extensively debated and recent advances in unilateral parathyroidectomy intensify this controversy. The purpose of this study was to review the parathyroidectomy experience of a single surgeon, looking at the role of sestamibi scans and a standard postoperative care regimen. STUDY DESIGN Retrospective review of office and hospital charts was completed on 90 patients with primary hyperparathyroidism who underwent parathyroidectomy from 1991 to 1998. Patient workup and outcomes were noted, as were results of preoperative imaging. True-positive scans visualized an abnormality ipsilateral to the adenoma found at operation. Statistics were performed using nonparametric testing and Students t-test. RESULTS There were 21 male and 69 female patients, with an average age of 54 years (range 29 to 81). There were zero mortalities, three morbidities (3.3%), and three patients who had persistent hypercalcemia, yielding a 96.7% success rate. Sixty-seven patients underwent preoperative sestamibi scanning, with a sensitivity of 74% and positive predictive value of 89%. Operative time in imaged patients averaged 103 +/- 49.9 minutes versus 121.5 +/- 85.9 minutes for patients without sestamibi scans. Operating time differences were not statistically significant and a preoperative sestamibi scan did not affect the success of parathyroidectomy. Discharge on postoperative day 1 was accomplished in 80% of patients and 13% were discharged the next day. There was no morbidity from hypocalcemia. CONCLUSIONS A preoperative sestamibi scan does not improve efficacy or decrease operating time for primary hyperparathyroidism when bilateral neck exploration is performed. A postoperative care protocol including oral calcium and vitamin D supplementation allows the majority of patients to be discharged on postoperative day 1 with excellent results.


Journal of Surgical Research | 2012

Perioperative Surgical Care Bundle Reduces Pancreaticoduodenectomy Wound Infections

Harish Lavu; Matthew Klinge; Leonard J. Nowcid; Herbert E. Cohn; Dane R. Grenda; Patricia K. Sauter; Benjamin E. Leiby; Sean P. Croker; Eugene P. Kennedy; Charles J. Yeo

BACKGROUND Pancreaticoduodenectomy (PD) is a complex surgical procedure with a historically high morbidity rate. The goal of this study was to determine if the implementation of a 12-measure perioperative surgical care bundle (SCB) was successful in reducing infectious and other complications in patients undergoing PD compared with a routine preoperative preparation group (RPP). METHODS In this retrospective cohort study utilizing the HPB surgery database at the Thomas Jefferson University, we analyzed clinical data from 233 consecutive PDs from October 2005 to May 2008 on patients who underwent RPP, and compared them with 233 consecutive PDs from May 2008 to May 2010 following the implementation of the SCB. The SCB was the product of multidisciplinary discussion and extensive literature review. RESULTS The RPP group and the SCB group had similar demographic characteristics. The overall rate of postoperative morbidity was similar between groups (42.1% versus 37.8%). However, wound infections were significantly lower in the SCB group (15.0% versus 7.7%, P = 0.01).The rates of other common complications, as well as postoperative hospital length of stay, readmissions, and 30-d postoperative mortality were similar between groups. CONCLUSIONS The implementation of a SCB was followed by a significant decline in wound infection in patients undergoing PD.


Spine | 1985

The use of autografts for vertebral body replacement of the thoracic and lumbar spine

Howard B. Cotler; Jerome M. Cotler; Amy Stoloff; Herbert E. Cohn; Bruce E. Jerrell; Lucas Martinez; Bruce E. Northrup; Jewell L. Osterholm; Francis E. Rosato

Thirty-seven patients with fractures of the thoracic or lumbar spine underwent anterior corpectomy (partial or complete) and vertebral body replacement for either destructive lesions from tumor or infection (13 patients) or trauma (24 patients). The vertebral bodies were replaced using either rib (12 patients) or tricortical iliac crest (25 patients) autografts. The Dunn device was utilized in conjunction with the autografts in 19 patients. Posterior stabilization was used in five patients; three prior to anterior stabilization and two after anterior stabilization. Within 2 weeks of the operative procedure, all patients began walking or sitting. Of the 37 patients, 21 with incomplete neurologic deficits improved, and 10 of those went onto complete recovery. Of the 27 patients who have been followed for a minimum of 1 year, 25 have obtained solid fusions, one developed a pseudarthrosis that required regrafting, and one had a delayed union prior to death from metastatic disease. There were two deaths in the immediate postoperative period and three deaths in the first six postoperative wounds due to metastatic disease. The purpose of this study is to present a consecutive series of patients who have undergone corpectomy and vertebral body replacement as well as to define the adequacy of stabilization.


Spine | 1983

Intrathoracic chordoma presenting as a posterior superior mediastinal tumor.

Howard B. Cotler; Jerome M. Cotler; Herbert E. Cohn; Harold Israel; John Gartland

A case of thoracic chordoma successfully treated with surgical excision is reported and described. Thoracic chordomata presenting as posterior superior mediastinal tumors occur infrequently and may be highly malignant lesions. Early radical surgery through thoracotomy provide the best hope of cure, and radiation offers only temporary regression of tumor.


Annals of Otology, Rhinology, and Laryngology | 1987

Congenital Bronchoesophageal Fistula in the Adult

B. Davison Smith; Diran O. Mikaelian; Herbert E. Cohn

Congenital bronchoesophageal fistulas usually present in infants and may occur with or without esophageal atresia. Twenty cases of congenital bronchoesophageal fistula in adults have been reported in the English literature. Another case of this rare developmental anomaly is presented here. The radiographic, endoscopic, surgical, and pathologic findings are discussed with a review of the literature.


Annals of Otology, Rhinology, and Laryngology | 1984

Granular Cell Tumor of the Trachea

Diran O. Mikaelian; Harold Israel; Herbert E. Cohn; Zaven Jabourian

Granular cell tumors are rare neoplasms that arise in different regions of the body. Their cell of origin is still debated among many pathologists, but recent authors consider them to be neurogenic. These tumors are believed to be benign; however, local recurrences after excision and multifocality arouse suspicions for malignancy. In the head and neck, granular cell tumors occur most frequently in the tongue. In the laryngotracheobronchial tree, most tumors reported have been in the larynx and the next most in the bronchi. Only six cases of true tracheal occurrences have been reported previously; two additional cases are reported in this paper. The literature of the cell of origin of these tumors is reviewed, the different theories are presented, and diagnosis, treatment, and follow-up are discussed.

Collaboration


Dive into the Herbert E. Cohn's collaboration.

Top Co-Authors

Avatar

Francis E. Rosato

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adam C. Berger

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Charles J. Yeo

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Ernest L. Rosato

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

John C. Kairys

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

John L. Farber

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Karen A. Chojnacki

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Matthew Wilson

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Arthur S. Patchefsky

Thomas Jefferson University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge